Audien Hearing Atom vs Resound Vivia 9 60S microRIE

The Audien Hearing Atom is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.3/5 in HearAdvisor's lab testing. At $89, it's positioned as an entry-level option in the visible-in-ear category, ranking #52 of 65 OTC hearing aids tested. In our testing, the Atom demonstrates mixed results across key performance areas. Its standout strength is excellent feedback handling, scoring a perfect 5.0/5—0.46 points above the category average. This means users can expect stable performance without whistling or squealing during typical wear. However, speech clarity metrics fall below category averages: speech in quiet scores 2.6/5 (0.15 points below average) and speech in noise scores a low 1.0/5 (0.48 points below average), which may limit effectiveness in challenging listening environments. The Atom does not support music streaming, scoring 0.0/5 in this category—1.92 points below the OTC average. Own-voice comfort is mixed at 2.1/5, sitting 0.41 points below the category average. These limitations are notable when compared to similarly-priced alternatives like the Elehear Beyond (4.36/5) or Apple AirPods Pro 2 (4.06/5), which offer substantially stronger overall performance. This device may suit budget-conscious consumers who prioritize basic amplification and feedback-free wear over speech clarity in noise or streaming capabilities. Those seeking stronger speech performance or music features should consider higher-scoring alternatives in this price range.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.